Organigram Global Inc. Files 6-K, Opts for Form 40-F

Ticker: OGI · Form: 6-K · Filed: Apr 16, 2025 · CIK: 1620737

Sentiment: neutral

Topics: reporting, sec-filing, foreign-private-issuer

TL;DR

Organigram Global Inc. filed a 6-K, confirming they'll use Form 40-F for their annual report.

AI Summary

Organigram Global Inc. filed a Form 6-K on April 16, 2025, indicating it will file its annual report under Form 40-F. The company, formerly Organigram Holdings Inc., is based in Toronto, Canada, and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing signals Organigram's compliance with SEC reporting requirements for foreign private issuers, specifically its intention to use Form 40-F for its annual report.

Risk Assessment

Risk Level: low — The filing is a routine procedural disclosure regarding reporting form selection, not indicating any new operational or financial risks.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to indicate that Organigram Global Inc. will file its annual report under cover of Form 40-F.

What is the filing date of this report?

The filing date is April 16, 2025.

What is the principal executive office address of Organigram Global Inc.?

The principal executive office is located at 145 King Street West, Suite 1400, Toronto, Ontario, Canada M5H 1J8.

Has Organigram Global Inc. changed its name previously?

Yes, the company was formerly known as Organigram Holdings Inc., with name changes recorded on August 31, 2016, and September 26, 2014.

Under which SEC Act is this report filed?

This report is filed under the Securities Exchange Act of 1934.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 16, 2025 regarding ORGANIGRAM GLOBAL INC. (OGI).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing